Billionaire Profile
Egor Kulkov
Global Rank
#910

Image: Unsplash Contributor | Unsplash License | via Unsplash

Egor Kulkov

CEO, Pharmaceuticals
RUSSIA
Real-Time Net Worth
$4.72B
Estimated based on Pharmaceuticals stock value as of April 20, 2026
0% (24h)
Age
54
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
RUSSIA

Biography

Egor Kulkov, a prominent figure in the pharmaceutical industry, has built a substantial fortune through strategic investments and entrepreneurial ventures. Born in 1971, Kulkov's career began with early investments and partnerships that led him to co-found Pharmstandard in 2003. Today, he maintains a significant stake in Pharmstandard, now a leading pharmaceutical firm in Russia. Kulkov's net worth is estimated at $4.7 billion, reflecting his success in the healthcare sector and strategic investments. Beyond Pharmstandard, Kulkov holds shares in other pharmaceutical companies and is a significant shareholder in the British medical technology firm CMR Surgical. His career and achievements have established him as a key player in the global pharmaceutical landscape.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/20/2026

Wealth Over Time

In-Depth Profile

Early Life

Egor Nikolaevich Kulkov was born on December 7, 1971, in Novosibirsk, Russia. He earned a Master of Science degree from Novosibirsk State University. During his studies, he formed a pivotal partnership with Viktor Kharitonin. In 1993, they co-founded the trading firm “Kreditinform.”

Rise to Success

Kulkov's career saw a pivotal shift in 1999 when he and Viktor Kharitonin acquired the UfaVita plant, marking their initial foray into the pharmaceutical sector. Their significant breakthrough came in 2003 when, alongside Roman Abramovich and others, they established Pharmstandard by consolidating five factories purchased from ICN Pharmaceuticals. By 2008, Kulkov and Kharitonin had bought out their partners, solidifying their control over Pharmstandard.

Key Business Strategies

Kulkov's business acumen is evident in his ability to identify and invest in ventures with substantial growth potential. He holds stakes in Russian pharmaceutical firms OTCPharm, Biocad, and Generium. He is also the largest shareholder of the British medical technology firm CMR Surgical, renowned for its Versius surgical robotic system.

Philanthropy

Beyond his entrepreneurial pursuits, Egor Kulkov is known for his philanthropic activities. He has supported various charitable initiatives in Russia, focusing on education, healthcare, and environmental conservation. His foundation has funded scholarships for disadvantaged youth and has contributed to the restoration of cultural heritage sites across the country.

Career Milestones

1993

Co-founded Kreditinform

Co-founded the trading firm Kreditinform with Viktor Kharitonin.

1999

Acquired UfaVita plant

Ventured into the pharmaceutical sector with the acquisition of the UfaVita plant.

2003

Co-founded Pharmstandard

Established Pharmstandard, consolidating factories from ICN Pharmaceuticals.

2008

Bought out partners in Pharmstandard

Solidified control over Pharmstandard by buying out the partners with Viktor Kharitonin.

2024

Shareholder of CMR Surgical

Largest shareholder of the British medical technology firm CMR Surgical.

Philanthropy & Social Impact

Charity

Charitable Initiatives in Russia

Undisclosed

Supports charitable initiatives in Russia focusing on education, healthcare, and environmental conservation.